Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Pneumonia caused by Chlamydia species in children

Dori F Zaleznik, MD
Jesus G Vallejo, MD
Section Editors
Morven S Edwards, MD
Robert A Wood, MD
Deputy Editor
Mary M Torchia, MD


The Chlamydia species are obligate, intracellular bacteria. Chlamydia trachomatis is a major cause of genital tract and ocular infections worldwide. (See "Chlamydia trachomatis infections in the newborn" and "Clinical manifestations and diagnosis of Chlamydia trachomatis infections" and "Treatment of Chlamydia trachomatis infection".)

Chlamydia pneumoniae and less often Chlamydia psittaci cause atypical pneumonia. C. trachomatis typically causes conjunctivitis and/or pneumonia in neonates, but also may affect young infants [1]. (See "Pneumonia in children: Epidemiology, pathogenesis, and etiology" and "Psittacosis" and "Chlamydia trachomatis infections in the newborn".)


Chlamydia species are unusual bacteria in several ways. The genome of the organisms is only 660 million daltons, smaller than any other prokaryote except mycoplasma. They do not contain a peptidoglycan in the cell wall. The growth cycle of the organism is complex and biphasic, consisting of two distinct entities: elementary (EB) and reticulate bodies (RB) [2].

The form in which the bacterium multiplies is the RB, which is intracellular. Replication occurs within a membrane-bound inclusion. RB are unstable and revert to EB within the inclusion, which then ruptures, causing release of EB, which are the form that survives in the extracellular environment; EB are the infectious particles.

The signal that triggers RB to EB reversion is not known. EB attach to epithelial cells and enter cells via a phagosome. Once inside, EB reorganize to RB, which then replicate.


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Sep 2016. | This topic last updated: Apr 27, 2015.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
  1. Rours GI, Hammerschlag MR, Van Doornum GJ, et al. Chlamydia trachomatis respiratory infection in Dutch infants. Arch Dis Child 2009; 94:705.
  2. Jones RB. Introduction to Chlamydial diseases. In: Principles and Practice of Infectious Diseases, 4th ed, Mandell GL, Bennett JE, Dolin R (Eds), Churchill Livingstone, New York 1995. p.1676.
  3. Shirai M, Hirakawa H, Kimoto M, et al. Comparison of whole genome sequences of Chlamydia pneumoniae J138 from Japan and CWL029 from USA. Nucleic Acids Res 2000; 28:2311.
  4. Shirai M, Hirakawa H, Ouchi K, et al. Comparison of outer membrane protein genes omp and pmp in the whole genome sequences of Chlamydia pneumoniae isolates from Japan and the United States. J Infect Dis 2000; 181 Suppl 3:S524.
  5. Morrison RP, Manning DS, Caldwell HD. Immunology of Chlamydia trachomatis infections. In: Immunology of Chlamydia trachomatis infections, Quinn TC (Ed), Raven Press, New York 1992. p.57.
  6. Emre U, Roblin PM, Gelling M, et al. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med 1994; 148:727.
  7. Emre U, Sokolovskaya N, Roblin PM, et al. Detection of anti-Chlamydia pneumoniae IgE in children with reactive airway disease. J Infect Dis 1995; 172:265.
  8. Myhra W, Mordhorst CH, Wang SP, et al. Clinical features of Chlamydia pneumoniae, strain TWAR, infection in Denmark 1975-1987. In: Chlamydial Infections, Bowie WR, Caldwell HD, Jones RP (Eds), Cambridge University Press, New York 1980. Vol 1990, p.422.
  9. Jackson LA. Chlamydia (Chlamydophila) pneumoniae. In: Principles and Practice of Infectious Diseases, 6th ed, Mandell GL, Bennett JE, Dolin R (Eds), Churchill Livingstone, Philadelphia 2005. p.2258.
  10. Wubbel L, Muniz L, Ahmed A, et al. Etiology and treatment of community-acquired pneumonia in ambulatory children. Pediatr Infect Dis J 1999; 18:98.
  11. Michelow IC, Olsen K, Lozano J, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 2004; 113:701.
  12. Kurz H, Göpfrich H, Wabnegger L, Apfalter P. Role of Chlamydophila pneumoniae in children hospitalized for community-acquired pneumonia in Vienna, Austria. Pediatr Pulmonol 2009; 44:873.
  13. Hammerschlag MR, Kohlhoff SA. Chlamydia infections. In: Feigin and Cherry’s Textbook of Pediatric Infectious Diseases, 7th, Cherry JD, Harrison GJ, Kaplan SL, et al. (Eds), Elsevier Saunders, Philadelphia 2014. p.2631.
  14. Tuuminen T, Palomäki P, Paavonen J. The use of serologic tests for the diagnosis of chlamydial infections. J Microbiol Methods 2000; 42:265.
  15. Chirgwin K, Roblin PM, Gelling M, et al. Infection with Chlamydia pneumoniae in Brooklyn. J Infect Dis 1991; 163:757.
  16. Grayston JT, Aldous MB, Easton A, et al. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. J Infect Dis 1993; 168:1231.
  17. Bourke SJ, Lightfoot NF. Chlamydia pneumoniae: defining the clinical spectrum of infection requires precise laboratory diagnosis. Thorax 1995; 50 Suppl 1:S43.
  18. Suesaowalak M, Cheung MM, Tucker D, et al. Chlamydophila pneumoniae myopericarditis in a child. Pediatr Cardiol 2009; 30:336.
  19. Kauppinen MT, Lähde S, Syrjälä H. Roentgenographic findings of pneumonia caused by Chlamydia pneumoniae. A comparison with streptococcus pneumonia. Arch Intern Med 1996; 156:1851.
  20. Gaydos CA, Roblin PM, Hammerschlag MR, et al. Diagnostic utility of PCR-enzyme immunoassay, culture, and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients. J Clin Microbiol 1994; 32:903.
  21. Murdoch DR. Molecular genetic methods in the diagnosis of lower respiratory tract infections. APMIS 2004; 112:713.
  22. Kumar S, Hammerschlag MR. Acute respiratory infection due to Chlamydia pneumoniae: current status of diagnostic methods. Clin Infect Dis 2007; 44:568.
  23. Harris JA, Kolokathis A, Campbell M, et al. Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children. Pediatr Infect Dis J 1998; 17:865.
  24. Numazaki K, Sakamoto Y, Umetsu M, et al. Therapeutic effect of clarithromycin for respiratory-tract infections in children caused by Chlamydia pneumoniae. Research Group of Sapporo for Pediatric Chlamydial Infections. Int J Antimicrob Agents 2000; 13:219.
  25. Lee PI, Wu MH, Huang LM, et al. An open, randomized, comparative study of clarithromycin and erythromycin in the treatment of children with community-acquired pneumonia. J Microbiol Immunol Infect 2008; 41:54.
  26. Meyerhoff A, Albrecht R, Meyer JM, et al. US Food and Drug Administration approval of ciprofloxacin hydrochloride for management of postexposure inhalational anthrax. Clin Infect Dis 2004; 39:303.